BYJU'S: The Rise and Fall of India's Most Valuable Startup (A Complete Post-Mortem)
BYJU'S peaked at a $22B valuation. It is now valued at near zero. This is not a story about fraud, though there was fraud. It's a story about a business that was never as good as its fundraising.
Get 1 unfair insight every week from India's startup ecosystem.
Read by serious founders and investors. No fluff.
“BYJU'S core business model — financing education purchases through high-pressure sales and third-party loans — was not an edtech business. It was a consumer lending business with an app attached. When NBFC partners tightened lending standards, the revenue vanished overnight.”
“The $22B valuation was built on reported ARR that included revenue recognized from multi-year subscription contracts upfront — a practice that inflated current-period revenue while deferring the risk of non-payment and cancellation into future periods that never resolved favorably.”
“The acquisition spree — Aakash, Toppr, WhiteHat Jr, Epic — destroyed capital at a rate that turned BYJU'S from an operationally complex edtech into an operationally impossible conglomerate. Each acquisition added cost without adding a clear path to the unit economics its core business lacked.”
Continue reading with Blog Pass
This piece is part of the Aletheia archive. This week’s drops are free — unlock every sector thesis, deal-flow breakdown and disclosure note with a Blog Pass.
Most founders reading this won't act on it.
The ones who will, get our next insight first.
Amit Tyagi
Founder, AletheiaAI & GP, Fitoor Capital
Veteran of India's startup ecosystem. Writing about fundraising, investor psychology, and what it takes to build fundable startups in India.
Run a fundability check
AletheiaAI audits your revenue recognition and unit economics before investors do — identifying the gaps that turn promising decks into difficult diligence conversations.
Don’t miss the next one
One insight every week. No fluff.
Sector theses, product teardowns, founder lessons, and Indian unicorn deconstructions. Read by founders preparing to raise and investors building conviction.
One contrarian insight. Every week. No generic startup advice.
Join founders and investors building with better information.